Tag: board
-
Valeant to appoint interim CEO as Pearson remains hospitalized: source
By Sneha Banerjee and Carl O'Donnell (Reuters) – Valeant Pharmaceuticals International Inc will appoint an interim chief executive officer to replace Michael Pearson who is hospitalized, a source familiar with the matter told Reuters, news that sent shares down 7 percent on Tuesday. The source did not clarify whether the CEO would be temporary or…
-
Valeant plans to appoint new CEO as Pearson remains hospitalized: WSJ
(Reuters) – Valeant Pharmaceuticals International Inc is planning to appoint a new CEO as Chief Executive Michael Pearson remains hospitalized, the Wall Street Journal said, citing people familiar with the matter. The new chief executive would replace the committee currently running the company, the newspaper said. Potential new chief executive candidates include Chief Financial Officer…
-
Eli Lilly’s diabetes pill takes market share from J&J, Astra
Eli Lilly and Co’s new Jardiance diabetes treatment has begun stealing market share from rival drugs in its class, the company said on Tuesday, bolstered by clinical trial data showing it slashed deaths by 32 percent in patients with Type 2 diabetes. In a three-year study whose results were released last summer, Jardiance became the…
-
Valeant CEO Pearson remains hospitalized for pneumonia: Bloomberg
Valeant Pharmaceuticals International Inc Chief Executive J. Michael Pearson has been moved to another hospital where he is being treated for a severe case of pneumonia, a company spokeswoman told Bloomberg on Sunday. Elaine Andrecovich, a public relations manager at Morristown Medical Center, where Pearson initially was admitted for treatment on Friday, confirmed that Pearson…
-
Manning angrily denies Al Jazeera report he obtained PEDs
ENGLEWOOD, Colo. (AP) — Peyton Manning said a report by Al Jazeera set to air Sunday that suggests he obtained performance-enhancing drugs was “completely fabricated, complete trash, garbage.”
-
Valeant says CEO J. Michael Pearson hospitalized with severe pneumonia
Valeant Pharmaceuticals International Inc Chief Executive J. Michael Pearson was hospitalized with a “severe case of pneumonia” on Friday and is receiving treatment, a company spokeswoman said. Pearson, 56, joined Valeant as CEO in September 2010 after a 23-year career at McKinsey & Company and became chairman of the board in 2010. Under Pearson's leadership,…
-
Valeant says CEO J. Michael Pearson hospitalized with severe pneumonia
Valeant Pharmaceuticals International Inc Chief Executive J. Michael Pearson was hospitalized with a “severe case of pneumonia” on Friday and is receiving treatment, a company spokeswoman said. Pearson, 56, joined Valeant as CEO in September 2010 after a 23-year career at McKinsey & Company and became chairman of the board in 2010. Under Pearson's leadership,…